Serum prostate-antigen levels in patients with benign prosttic hypertrophy treated with leuprolide
- 31 July 1989
- Vol. 34 (1), 10-13
- https://doi.org/10.1016/0090-4295(89)90147-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- EFFECT OF A GNRH ANALOGUE (LEUPROLIDE) ON BENIGN PROSTATIC HYPERTROPHYJournal of Clinical Endocrinology & Metabolism, 1987
- Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasmsCancer, 1981
- Prostate antigen: A new potential marker for prostatic cancerThe Prostate, 1981
- The pathogenesis of benign prostatic hyperplasiaAmerican Journal Of Medicine, 1980
- Stromal-Epithelial Interactions in Sex DifferentiationBiology of Reproduction, 1980
- INHIBITORY EFFECTS ON GONADOTROPHIN SECRETION AND GONADAL FUNCTION IN MEN DURING CHRONIC TREATMENT WITH A POTENT STIMULATORY LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUEActa Endocrinologica, 1979
- The Effect of Orchiectomy and Estrogens on Benign Prostatic HyperplasiaJournal of Urology, 1972
- Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone AcetateJournal of Urology, 1969
- The Effect of Castration on Benign Hypertrophy of the Prostate in ManJournal of Urology, 1940